Compensation for Cures: Paying People to Participate in Challenge Studies

Bioethics 33 (7):792-797 (2019)
  Copy   BIBTEX

Abstract

Antibiotic resistance is one of the most pressing public health problems humanity faces. Research into new classes of antibiotics and new kinds of treatments – including risky experimental treatments such as phage therapy and vaccines – is an important part of improving our ability to treat infectious diseases. In order to aid this research, we will argue that we should permit researchers to pay people any amount of money to compensate for the risks of participating in clinical trials, including ‘challenge studies’ that involve deliberately infecting patients. We think that standard worries about paying for participation in risky research are reducible to concerns that can be addressed with the right screening mechanisms.

Author Profiles

Julian Savulescu
Oxford University
Jonathan Anomaly
Duke University

Analytics

Added to PP
2018-04-17

Downloads
586 (#28,781)

6 months
87 (#55,202)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?